Sarah Ludlow, MD
Family Medicine · Fenton, MONPI 1053676593
Payments from drug & device makers
Across 27 payments — averaging $105.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$2K
- Galderma Laboratories, L.p.$359
- Exact Sciences$53
- Sumitomo Pharma America, Inc.$1
What the payments were for
- Travel & lodging$1,42650%
- Food & beverage$1,42550%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 17 | $2,438 |
| Galderma Laboratories, L.p. | 6 | $359 |
| Exact Sciences | 3 | $53 |
| Sumitomo Pharma America, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$1,927
How this compares
$2,852 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 217 | $309,900 |
| EliquisApixaban | 210 | $195,697 |
| JardianceEmpagliflozin | 98 | $123,017 |
| MounjaroTirzepatide | 55 | $87,075 |
| XareltoRivaroxaban | 50 | $60,864 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 156 | $39,112 |
| FarxigaDapagliflozin Propanediol | 26 | $39,021 |
| JanuviaSitagliptin Phosphate | 31 | $38,272 |
| MyrbetriqMirabegron | 24 | $30,213 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $28,249 |
| TrulicityDulaglutide | 18 | $25,520 |
| LinzessLinaclotide | 21 | $23,658 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 34 | $15,881 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 55 | $14,709 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 19 | $13,837 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fenton
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.